{"created":"2023-06-19T10:29:44.360673+00:00","id":1836,"links":{},"metadata":{"_buckets":{"deposit":"724c8655-1a72-4547-890c-06f1e3a330f6"},"_deposit":{"created_by":31,"id":"1836","owners":[31],"pid":{"revision_id":0,"type":"depid","value":"1836"},"status":"published"},"_oai":{"id":"oai:kwmed.repo.nii.ac.jp:00001836","sets":["1709617079800:35:325:597"]},"author_link":["110701","110702"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2016","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"77","bibliographicPageStart":"69","bibliographicVolumeNumber":"42","bibliographic_titles":[{"bibliographic_title":"川崎医学会誌","bibliographic_titleLang":"ja"},{"bibliographic_title":"Kawasaki medical journal","bibliographic_titleLang":"en"}]}]},"item_10001_description_33":{"attribute_name":"記事種別(日)","attribute_value_mlt":[{"subitem_description":"原著論文","subitem_description_language":"ja","subitem_description_type":"Other"}]},"item_10001_description_34":{"attribute_name":"記事種別(英)","attribute_value_mlt":[{"subitem_description":"Regular Article","subitem_description_language":"en","subitem_description_type":"Other"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"川崎医学会","subitem_publisher_language":"ja"}]},"item_10001_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.11482/KMJ-J42(2)69","subitem_relation_type_select":"DOI"}}]},"item_10001_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://igakkai.kms-igakkai.com/wp/wp-content/uploads/2016/KMJ-J42(2)69.pdf","subitem_relation_type_select":"URI"}}]},"item_10001_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00045593","subitem_source_identifier_type":"NCID"},{"subitem_source_identifier":"AN12940574","subitem_source_identifier_type":"NCID"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0386-5924","subitem_source_identifier_type":"PISSN"},{"subitem_source_identifier":"2758-089X","subitem_source_identifier_type":"EISSN"}]},"item_10001_text_31":{"attribute_name":"著者所属(日)","attribute_value_mlt":[{"subitem_text_language":"ja","subitem_text_value":"川崎医科大学精神科学"}]},"item_10001_text_32":{"attribute_name":"著者所属(英)","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"Department of Psychiatry, Kawasaki Medical School"}]},"item_10001_textarea_5":{"attribute_name":"抄録(英)","attribute_value_mlt":[{"subitem_textarea_language":"en","subitem_textarea_value":"In recent years, it has been noted that treatment of psychiatric disorders comorbid with attention-deficit/hyperactivity disorder (ADHD) tends to be difficult. ADHD often co-occurs with alcohol-use disorders coexist. The clinical features of these comorbid conditions have not yet been studied. This study investigated these clinical features in adult patients.\nWe investigated for 33 patients who had a diagnosis of alcohol-use disorder, as defined by the DSM-5, who were 20 years or older. We divided them into a group with comorbid ADHD (ADHD group) and a non-ADHD group, and evaluated the symptoms using the Alcohol Relapse Risk Scale (ARRS), Conners’s Adult ADHD Rating Scale Japanese version (CAARS), the Beck Depression Inventory　Second Edition (BDI-II), and the Autism Spectrum Quotient Japanese version (AQ-J).\nWe found that the ARRS total score was significantly higher in the ADHD group, with the “stimulus-induced vulnerability,” “emotional problems” “positive expectancy for alcohol” in sub-items being significantly higher in the ADHD group than in the non-ADHD group. In addition, the total score of the BDI-II was also significantly higher in the ADHD group than in the non-ADHD group.\nPatients with alcohol-use disorders have a significant relapse risk, and when comorbid for ADHD, such patients have even higher subjective depressive symptoms. Relapse may be prevented by attending to these symptoms by giving medical care."}]},"item_10001_textarea_6":{"attribute_name":"抄録(日)","attribute_value_mlt":[{"subitem_textarea_language":"ja","subitem_textarea_value":"精神科臨床において，他の精神疾患に注意欠如多動症（Attention Deficit Hyperactivity Disorder ; ADHD）が併存することで，治療が困難になりやすいことが近年注目されている．アルコール使用障害患者において，ADHD の併存が多いことは報告されているが，その臨床特徴が再飲酒にどのように影響するかについての研究はこれまでなく，本研究ではそれらを検討した．\nDSM-5によってアルコール使用障害と診断された20歳以上の患者33名を対象とし，ADHD 群と非ADHD群に分け，アルコール再飲酒リスク評価尺度（ARRS：Alcohol Relapse Risk Scale），コナーズ成人ADHD 評価スケール日本語版（CAARS：Conners’ Adult ADHD Rating Scale），ベックうつ病評価尺度（BDI-II：Beck Depression Inventory-Second Edition），自閉症スペクトラム指数日本語版（AQ-J：Autism Spectrum Quotient-Japanese Version）を用いて症状を評価した．\n結果は，ADHD 群でARRS 総得点が有意に高く，下位項目でも「刺激脆弱性」「感情面の問題」「ポジティブ期待」が有意に高かった．また，BDI-IIにおいてもADHD 群が有意に高かった．\nアルコール使用障害患者は，ADHD を伴うと再飲酒リスクが有意に上がり，自覚的な抑うつ症状も有意に高いことが示された．これらに留意して診療を行うことで，再飲酒を防ぐ可能性があることが示唆された．"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"原, 正吾","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"110701","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"HARA, Shogo","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"110702","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-03-09"}],"displaytype":"detail","filename":"KMJ-J42(2)69.pdf","filesize":[{"value":"865.8 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"PDF","objectType":"fulltext","url":"https://kwmed.repo.nii.ac.jp/record/1836/files/KMJ-J42(2)69.pdf"},"version_id":"78578c66-6548-4efa-840f-966e965e5fd0"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"アルコール使用障害","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"注意欠如多動症","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"再飲酒リスク","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"Alcohol use disorder","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"ADHD","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Relapse risk","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"注意欠如多動症を併存するアルコール使用障害患者の臨床的特徴","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"注意欠如多動症を併存するアルコール使用障害患者の臨床的特徴","subitem_title_language":"ja"},{"subitem_title":"Clinical features of alcohol use disorder patients comorbid attention deficit hyperactivity disorder","subitem_title_language":"en"}]},"item_type_id":"10001","owner":"31","path":["597"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2017-03-09"},"publish_date":"2017-03-09","publish_status":"0","recid":"1836","relation_version_is_last":true,"title":["注意欠如多動症を併存するアルコール使用障害患者の臨床的特徴"],"weko_creator_id":"31","weko_shared_id":-1},"updated":"2024-04-16T02:02:51.260381+00:00"}